Tags

Type your tag names separated by a space and hit enter

Safety issues with drug therapies for autism spectrum disorders.
J Clin Psychiatry. 2005; 66 Suppl 10:32-7.JC

Abstract

Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.

Authors+Show Affiliations

Neuropsychiatric Institute, University of California, Los Angeles, CA, USA. jmccracken@mednet.ucla.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16401148

Citation

McCracken, James T.. "Safety Issues With Drug Therapies for Autism Spectrum Disorders." The Journal of Clinical Psychiatry, vol. 66 Suppl 10, 2005, pp. 32-7.
McCracken JT. Safety issues with drug therapies for autism spectrum disorders. J Clin Psychiatry. 2005;66 Suppl 10:32-7.
McCracken, J. T. (2005). Safety issues with drug therapies for autism spectrum disorders. The Journal of Clinical Psychiatry, 66 Suppl 10, 32-7.
McCracken JT. Safety Issues With Drug Therapies for Autism Spectrum Disorders. J Clin Psychiatry. 2005;66 Suppl 10:32-7. PubMed PMID: 16401148.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Safety issues with drug therapies for autism spectrum disorders. A1 - McCracken,James T, PY - 2006/1/13/pubmed PY - 2006/3/11/medline PY - 2006/1/13/entrez SP - 32 EP - 7 JF - The Journal of clinical psychiatry JO - J Clin Psychiatry VL - 66 Suppl 10 N2 - Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome. SN - 0160-6689 UR - https://www.unboundmedicine.com/medline/citation/16401148/Safety_issues_with_drug_therapies_for_autism_spectrum_disorders_ L2 - http://www.psychiatrist.com/jcp/article/pages/2005/v66s10/v66s1005.aspx DB - PRIME DP - Unbound Medicine ER -